-
Selonsertib in Hepatic Steatosis Research
2026-09-09
Selonsertib (GS-4997) offers a selective way to test whether ASK1–p38/JNK stress signaling contributes to Galectin-1-driven hepatic steatosis. This article develops a mechanistic assay framework that separates autophagy failure, oxidative stress signaling, and metabolic dysfunction without overstating the current evidence.
-
MK 0893: Glucagon Receptor Antagonist Workflow
2026-09-09
MK 0893 combines nanomolar glucagon receptor activity with a structurally defined allosteric mechanism, making it useful for receptor pharmacology, cAMP assays, and translational diabetes studies. This guide connects cell-based assay setup with in vivo interpretation, selectivity controls, and practical troubleshooting.
-
ATRNL1 and Cell-Specific Biology of Atrial Fibrillation
2026-09-08
This study applies large-scale single-nucleus RNA sequencing to human left atrial tissue and identifies ATRNL1 as a cardiomyocyte-associated gene linked to atrial fibrillation. Its combination of patient-derived profiling with genetic perturbation in human stem-cell-derived cardiomyocytes connects ATRNL1 to cellular stress responses and cardiac electrical activity, while also revealing cell-specific expression patterns that bulk tissue analysis could miss.
-
Quercetin Workflows for PI3K and Ferroptosis Research
2026-09-08
Build a reproducible Quercetin workflow that connects PI3K signaling, mitochondrial apoptosis, and ferroptosis without treating these endpoints as interchangeable. The approach combines practical dosing, orthogonal cell-death assays, lipid-peroxidation measurements, and troubleshooting guidance for cancer research and liver-injury models.
-
Hypoxia, Choroid Plexus, and Cognitive Impairment
2026-09-07
This study identifies choroid plexus barrier disruption as a key link between simulated high-altitude hypoxia and cognitive dysfunction in mice. Its mechanistic model connects aberrant AMPK signaling and oxidative stress with M1 macrophage polarization, providing a framework for studying neuroimmune contributions to hypoxia-related CNS injury.
-
Protease Inhibitor Cocktail for Rice Signaling
2026-09-07
Protect phosphorylation-sensitive rice proteins, complexes, and kinase readouts without introducing EDTA that can disrupt divalent-cation-dependent assays. This workflow translates the OsCDPK24/28–OsHSFA4d discovery into practical Western blot, co-immunoprecipitation, pull-down, and kinase assay decisions.
-
Meropenem: Mapping Carbapenemase-Driven Failure
2026-09-05
Meropenem is a β-lactam antibiotic carbapenem whose activity can be used to separate target inhibition from carbapenemase-mediated resistance. This research-focused guide translates recent CREC transmission findings into a practical framework for susceptibility, gene-mobility, formulation, and Gram-negative bacterial infection model design.
-
Cyclophosphamide: Mechanism-to-Assay Guide
2026-09-04
Cyclophosphamide is an alkylating chemotherapeutic agent whose experimental value depends on bioactivation, exposure timing, and endpoint selection. This guide connects DNA cross-linking, immune modulation, and assay design while using topoisomerase I pharmacology as a framework for avoiding mechanistic misinterpretation.
-
Bufuralol Hydrochloride as a Translational PK Probe
2026-09-04
Bufuralol hydrochloride offers a rigorous way to connect β-adrenergic pharmacology with human-relevant absorption and metabolism studies. This article presents an assay-decision framework using hiPSC-derived intestinal organoids without overstating what the model can predict.
-
PAD4-IN-2 TFA: Reframing Tumor-Targeted PAD4 Biology
2026-09-03
PAD4-IN-2 TFA, also known as Compound 5i TFA, links phenylboronic-acid-enabled tumor uptake with suppression of the PAD4–H3cit–NET axis. This article examines its mechanistic rationale, preclinical validation, immune-microenvironment effects, and practical value for translational cancer research.
-
AO/PI Double Staining Kit: Applied Workflow
2026-09-03
The AO/PI Double Staining Kit provides a rapid visual separation of viable, apoptotic, and necrotic cells in one preparation. This guide translates that fluorescent readout into reproducible workflows for treatment screens, rare-cell recovery, and troubleshooting without overstating what the assay can prove mechanistically.
-
Phosbind Biotin LC: PVDF Detection Guide
2026-09-02
Phosbind Biotin LC is a phosphate-binding reagent for sequence-independent detection of phosphorylated proteins or peptides on PVDF membranes, helping address cases where phospho-specific antibodies are unavailable or unsuitable. It is intended for Western Blot workflows with streptavidin-HRP and chemiluminescence, but it should not be used in aqueous-only protocols or with long-term stored working solutions.
-
BCA Protein Quantification Kit K4102
2026-09-02
The Bicinchoninic Acid Assay (BCA) Protein Quantification Kit K4102 measures low-concentration total protein in dilute biochemical samples, including many detergent-containing preparations and cell lysates. It is intended for scientific research and sample normalization, not diagnostic, clinical, or medical testing.
-
BCA Protein Quantification Kit K4102 Guide
2026-09-01
The Bicinchoninic Acid Assay (BCA) Protein Quantification Kit K4102 supports total-protein measurement in dilute samples, including many detergent-containing biochemical preparations and cell lysates. It is intended for scientific research workflows such as sample normalization and should not be used for diagnostic, clinical, or medical testing.
-
Sodium Phosphate Dibasic: Matrix-Aware Assays
2026-09-01
Sodium phosphate dibasic is more than a routine buffer ingredient: its phosphate chemistry can shape assay comparability, especially in multi-species toxicity studies. This guide connects Na2HPO4 selection, matrix controls, and the sulfamonomethoxine evidence base to more defensible biological assay design.